<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.biomarkers-for-tb.net/news-and-events/RSS">
  <title>News and Events</title>
  <link>http://www.biomarkers-for-tb.net</link>
  
  <description>
    
       
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2007-07-17T11:20:56Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.biomarkers-for-tb.net/logo.jpg"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/grand-challenges-explorations-round-2-now-accepting-proposals"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/open-forum-3-2014-key-issues-in-tb-drug-development"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/events-folder/immunodiagnosis-of-tuberculosis-new-questions-new-tools"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/immunity-to-tuberculosis"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/tuberculosis-2007-a-medical-textbook"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/who-tb-report-2008"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/who-tb-drug-resistance-global-report-no.4"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/gcgh-explorations-first-period"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/handbook-of-tuberculosis"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/msf-symposium-on-tb-field-diagnostics"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/lasker-foundation-appoints-global-health-leader-as-new-president"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/intercell-launches-phase-i-clinical-trials-of-tb-vaccine"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/tag-publishes-2007-report"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/initial-release-of-three-xdr-tb-strains-from-kwazu-natal-in-south-africa"/>
        
        
            <rdf:li rdf:resource="http://www.biomarkers-for-tb.net/news-folder/integrated-tb-database"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/grand-challenges-explorations-round-2-now-accepting-proposals">        <title>Grand Challenges Explorations Round 2: Now Accepting Proposals</title>        <link>http://www.biomarkers-for-tb.net/news-folder/grand-challenges-explorations-round-2-now-accepting-proposals</link>        <description>The Bill &amp; Melinda Gates Foundation is now accepting grant proposals for Round 2 of Grand Challenges Explorations, a US$100 million initiative to encourage unconventional global health solutions. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-09-12T10:11:55Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/open-forum-3-2014-key-issues-in-tb-drug-development">        <title>Open Forum 3 — Key Issues in TB Drug Development</title>        <link>http://www.biomarkers-for-tb.net/news-folder/open-forum-3-2014-key-issues-in-tb-drug-development</link>        <description>This two-day Open Forum was the third in a series of meetings aimed to raise and address key issues in TB drug development, with a special focus on regulatory affairs. Speaker presentations are now available for download.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-06-05T09:27:13Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/events-folder/immunodiagnosis-of-tuberculosis-new-questions-new-tools">        <title>Immunodiagnosis of tuberculosis: new questions, new tools</title>        <link>http://www.biomarkers-for-tb.net/events-folder/immunodiagnosis-of-tuberculosis-new-questions-new-tools</link>        <description>Come and discuss the most recent developments in biomarkers discovery, diagnostic clinical trials, latest assay
technologies, and how discoveries in these fields can be translated into innovative tools for TB immunodiagnostics!  </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-05-23T09:04:48Z</dc:date>        <dc:type>Event</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/immunity-to-tuberculosis">        <title>Immunity to Tuberculosis</title>        <link>http://www.biomarkers-for-tb.net/news-folder/immunity-to-tuberculosis</link>        <description>An efis-EJI Symposium | 12-13 June 2008</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-05-19T09:58:06Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/tuberculosis-2007-a-medical-textbook">        <title>Tuberculosis 2007 | A Medical Textbook</title>        <link>http://www.biomarkers-for-tb.net/news-folder/tuberculosis-2007-a-medical-textbook</link>        <description>Tuberculosis 2007 is a medical textbook that provides a comprehensive and up-to-date overview of research, diagnosis and treatment of tuberculosis (687 pages).</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-05-19T09:14:44Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/who-tb-report-2008">        <title>WHO TB REPORT 2008</title>        <link>http://www.biomarkers-for-tb.net/news-folder/who-tb-report-2008</link>        <description>WORLDWIDE EFFORTS TO CONFRONT TUBERCULOSIS ARE MAKING PROGRESS, BUT TOO SLOW. This report is WHO's twelfth annual report on global tuberculosis control in a series that started in 1997.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-03-31T12:22:04Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/who-tb-drug-resistance-global-report-no.4">        <title>WHO TB Drug Resistance Global Report -No.4</title>        <link>http://www.biomarkers-for-tb.net/news-folder/who-tb-drug-resistance-global-report-no.4</link>        <description>26 FEBRUARY 2008 | WASHINGTON DC /GENEVA -- Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report published today. The report presents findings from the largest survey to date on the scale of drug resistance in tuberculosis.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-03-31T12:18:43Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/gcgh-explorations-first-period">        <title>Grand Challenges Explorations - First application acceptance period</title>        <link>http://www.biomarkers-for-tb.net/news-folder/gcgh-explorations-first-period</link>        <description>Innovative Ideas Accepted Beginning March 31, 2008.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>meesenburg</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-03-05T09:49:34Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/handbook-of-tuberculosis">        <title>Handbook of Tuberculosis</title>        <link>http://www.biomarkers-for-tb.net/news-folder/handbook-of-tuberculosis</link>        <description>The Handbook of Tuberculosis, 3 Volume Set, which explores the causes and available treatments of the widespread infection as well as current research into vaccination, is divided into three separate volumes covering different areas of study.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-01-30T12:17:15Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/msf-symposium-on-tb-field-diagnostics">        <title>MSF Symposium on TB field Diagnostics</title>        <link>http://www.biomarkers-for-tb.net/news-folder/msf-symposium-on-tb-field-diagnostics</link>        <description>Abstracts from MSF Symposium on TB field Diagnostics "TB: DYING for a TEST!" held at Cape Town on Nov 7, 2007 prior to 38th World Conference on Lung Health of IUATLD.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2007-12-21T12:53:48Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/lasker-foundation-appoints-global-health-leader-as-new-president">        <title>Lasker Foundation Appoints Global Health Leader as New President</title>        <link>http://www.biomarkers-for-tb.net/news-folder/lasker-foundation-appoints-global-health-leader-as-new-president</link>        <description>December 10, New York City  The Albert and Mary Lasker Foundation announced that Dr. Maria Freire will become President of the Lasker Foundation on March 1, 2008.  </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2007-12-11T12:29:43Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/intercell-launches-phase-i-clinical-trials-of-tb-vaccine">        <title>Intercell Launches Phase I Clinical Trials of TB Vaccine</title>        <link>http://www.biomarkers-for-tb.net/news-folder/intercell-launches-phase-i-clinical-trials-of-tb-vaccine</link>        <description>Austrian vaccine developer Intercell on Tuesday announced that it has launched Phase I clinical trials of a new preventive tuberculosis vaccine, APA Economics News Service reports.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2007-12-11T10:27:31Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/tag-publishes-2007-report">        <title>TAG publishes 2007 report</title>        <link>http://www.biomarkers-for-tb.net/news-folder/tag-publishes-2007-report</link>        <description>Tuberculosis Research &amp; Development:
A Critical Analysis of Funding Trends, 2005-2006</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2007-12-11T10:09:14Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/initial-release-of-three-xdr-tb-strains-from-kwazu-natal-in-south-africa">        <title>Genome of deadly TB strain decoded</title>        <link>http://www.biomarkers-for-tb.net/news-folder/initial-release-of-three-xdr-tb-strains-from-kwazu-natal-in-south-africa</link>        <description>Work of South Africa-US research team gives first look at genome of XDR TB;
Initial analysis highlights small number of DNA differences among drug-resistant and -sensitive microbes</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2007-11-23T10:15:09Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.biomarkers-for-tb.net/news-folder/integrated-tb-database">        <title>Integrated TB Database</title>        <link>http://www.biomarkers-for-tb.net/news-folder/integrated-tb-database</link>        <description>Integrated TB Database Project (PI - Gary Schoolnik from Stanford University in collaboration with Broad Institute) funded last year by BMGF has opened their web site.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>admin</dc:creator>        <dc:rights></dc:rights>                <dc:date>2008-05-21T10:52:19Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>
